BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Oka N, Orita Y, Oshita C, Nakayama H, Teragawa H. Primary malignant pericardial mesothelioma with difficult antemortem diagnosis: A case report. World J Clin Cases 2022; 10(33): 12380-12387 [PMID: 36483836 DOI: 10.12998/wjcc.v10.i33.12380]
URL: https://www.wjgnet.com/2307-8960/full/v10/i33/12380.htm
Number Citing Articles
1
Inga-Marie Schaefer, Adrian Mariño-Enríquez, Mark M. Hammer, Robert F. Padera, Lynette M. Sholl. Recurrent Tumor Suppressor Alterations in Primary Pericardial MesotheliomaModern Pathology 2023; 36(9) doi: 10.1016/j.modpat.2023.100237
2
Louise van der Weyden, Dewald Keet, Nicolize O’Dell. Primary Pericardial Well-Differentiated Papillary Mesothelioma in a Spotted Hyena (Crocuta crocuta)Veterinary Sciences 2025; 12(12) doi: 10.3390/vetsci12121170
3
Estera Pazek, Michał Sikorski, Michał Kapałka, Michał Krawiec, Grzegorz Hirnle, Tomasz Hrapkowicz. Primary pericardial mesothelioma: A cancer without prognosis? An epidemiological and clinical challengeAnnales Academiae Medicae Silesiensis 2025; (1) doi: 10.18794/aams/210316
4
Zijuan Liu, Yating Yan, Caihong Jiang. Case Report: Tislelizumab combined with bevacizumab in the treatment of primary malignant pericardial mesotheliomaFrontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1848097
5
Antibacterials/dopamineReactions Weekly 2023; 1951(1) doi: 10.1007/s40278-023-36816-4